<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02646709</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-MED-CT4-15-153</org_study_id>
    <nct_id>NCT02646709</nct_id>
  </id_info>
  <brief_title>The Effect of Different Dose of Ketamine With Low Dose Rocuronium in Children</brief_title>
  <official_title>The Effect of Different Doses of Ketamine on Tracheal Intubating Conditions Using Low Dose Rocuronium in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rocuronium is suitable for rapid induction within 60-90 seconds and its effect last 24-40
      minute after single bolus injection. For outpatient surgery with short operation time, low
      dose rocuronium is frequently used for rapid recovery at the expense of compromised
      intubating condition. For better intubating condition, ketamine can be used. However,
      appropriate dose of ketamine with low dose rocuronium is not established yet. This study, 3
      different doses of ketamine with low dose rocuronium will be compared for appropriate
      intubating condition.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intubation Condition</measure>
    <time_frame>during and after intubation, about 2 minute</time_frame>
    <description>5 variables will be individually evaluated though 3 point scale (excellent, good, poor). If all variables are graded as excellent, intubation condition will be excellent. If at least 1 variable is poor, it will be reported as poor. Otherwise, it will be reported as good.
Laryngoscope easiness
Vocal cord position
Vocal cord movement
Movement of limb
Coughing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>1. 1 min before induction 2.1 min after ketamine injection 3. 1min after intubation 4. 5 min after intubation 5. 10 min after intubation</time_frame>
    <description>heart rate will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time for extubation</measure>
    <time_frame>from the end of surgery to extubation, within 10 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>emergence agitation (4 points scale)</measure>
    <time_frame>5 min after postanesthesia care unit (PACU) admission</time_frame>
    <description>4 points scale
1: calm 2. cry but manageable 3. cry, not manageable 4. excitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACU time</measure>
    <time_frame>from PACU admission to discharge, about 30 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>severity of vomiting</measure>
    <time_frame>1. 1 min after PACU admission 2. 30 min after PACU admission</time_frame>
    <description>severity(0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic requirements (mg/kg)</measure>
    <time_frame>during PACU stay, about 30 min</time_frame>
    <description>if pain score exceed 3, fentanyl will be introduced. The total dose of fentanyl injection will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Desaturation</measure>
    <time_frame>during PACU stay, about 30 min</time_frame>
    <description>pulseoximeter will be applied and peripheral oxygen saturation less than 94 will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>1. 1 min before induction 2.1 min after ketamine injection 3. 1min after intubation 4. 5 min after intubation 5. 10 min after intubation</time_frame>
    <description>blood pressure will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of vomiting</measure>
    <time_frame>1. 1 min after PACU admission 2. 30 min after PACU admission</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>Ketamine 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine 1 mg/kg will be injected during induction. Low dose rocuronium (0.3 mg/kg) will be injected for muscle relaxation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine 1.5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine 1.5 mg/kg will be injected during induction. Low dose rocuronium (0.3 mg/kg) will be injected for muscle relaxation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine 2 mg/kg will be injected during induction. Low dose rocuronium (0.3 mg/kg) will be injected for muscle relaxation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Low dose rocuronium (0.3 mg/kg) will be injected after induction of anesthesia with ketamine.</description>
    <arm_group_label>Ketamine 1</arm_group_label>
    <arm_group_label>Ketamine 1.5</arm_group_label>
    <arm_group_label>Ketamine 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine 1</intervention_name>
    <description>ketamine 1 mg/kg will be injected for induction of anesthesia</description>
    <arm_group_label>Ketamine 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine 1.5</intervention_name>
    <description>ketamine 1.5 mg/kg will be injected for induction of anesthesia</description>
    <arm_group_label>Ketamine 1.5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine 2</intervention_name>
    <description>ketamine 2 mg/kg will be injected for induction of anesthesia</description>
    <arm_group_label>Ketamine 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA class I, II

        Exclusion Criteria:

          -  upper respiratory infection within 14 days

          -  anticipated difficult intubation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Go Un Roh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Go Un Roh, MD</last_name>
    <phone>82-31-219-6435</phone>
    <email>gone7968@aumc.ac.kr</email>
  </overall_contact>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>January 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2016</study_first_posted>
  <last_update_submitted>January 4, 2016</last_update_submitted>
  <last_update_submitted_qc>January 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Go Un Roh</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

